Genus plc Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/12/2026)
| Balance Sheet | Total Assets | 1,018,300,000.00 | ROE | 75.29 % |
| Balance Sheet | Total Equity | 766,700,000.00 | ROA | 28.02 % |
| Cashflow | Capital Expenditures | -12,500,000.00 | P/FCF | 20.00 |
| Cashflow | Free Cash Flow | 78,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 90,500,000.00 | P/CF | 17.23 |
| Income | Earnings per Share (diluted) | 0.26 | Div. Yield | 1.38 % |
| Income | Net Income | 285,300,000.00 | P/E | 5.47 |
| Income | Shares Outstanding | 67,113,000.00 | P/B | 2.03 |
| Income | Total Revenue | 658,100,000.00 | P/S | 2.37 |
Ratios calculated on: 10/14/2026
Company Description
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. Genus plc has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.genusplc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more